You should be paying more attention to your lungs. KU Med is helping you do it | Opinion
Survival rates for idiopathic pulmonary fibrosis are worse than all solid cancers except for lung and pancreatic cancer. | ...
Medscape21d
Genetics of Pulmonary Fibrosis: What Is Known and What's to Come?
Swigris, DO, MS: Hello. I'm Dr Jeff Swigris. Welcome to season 2 of the Medscape InDiscussion podcast series on idiopathic pulmonary fibrosis. Today we are going to discuss the topic of genetics ...
Pulmonary Fibrosis Foundation Launches Education Program For Newly Diagnosed Patients
The Pulmonary Fibrosis Foundation (PFF), the nation's leading pulmonary fibrosis (PF) research, education and advocacy ...
pulmonaryfibrosisnews1d
To my IPF community: Now is the time for legislative advocacy
Columnist Sam Kirton encourages the IPF community to get a jump on legislative advocacy before the new congressional term begins.
The American Journal of Managed Care28d
Identification, Course, and Management of Progressive Pulmonary Fibrosis
The term “progressive pulmonary fibrosis” or “PPF” is generally used to describe progressive lung fibrosis in an individual with an interstitial lung disease (ILD) other than idiopathic ...
Hosted on MSN7mon
Pulmonary fibrosis: what you need to know
Microsoft and our third-party vendors use cookies to store and access information such as unique IDs to deliver, maintain and improve our services and ads. If you agree, MSN and Microsoft Bing will ...
Kaleido Scope9mon
Pulmonary Fibrosis/Interstitial Lung Disease
The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). The University of ...
Hosted on MSN5mon
What is idiopathic pulmonary fibrosis (IPF)?
Microsoft and our third-party vendors use cookies to store and access information such as unique IDs to deliver, maintain and improve our services and ads. If you agree, MSN and Microsoft Bing ...
Aileron Therapeutics' Investigational Drug Shows Encouraging Action In Lung Fibrosis
On Wednesday, Aileron Therapeutics Inc (NASDAQ; ALRN) revealed topline data from Cohort 2 of its Phase 1b trial of safety and ...
Aileron Therapeutics Reports Positive Phase 1b Data Of LTI-03 In Idiopathic Pulmonary Fibrosis
(RTTNews) - Aileron Therapeutics, Inc. (ALRN), Wednesday announced positive topline data from the cohort 2 of Phase 1b study evaluating LTI-03 in patients with idiopathic pulmonary fibrosis (IPF).
Medscape11y
Influenza Vaccination in Children With Cystic Fibrosis
Cystic fibrosis (CF) is an inherited autosomal recessive disease characterized by progressive pulmonary damage and respiratory failure. It is known that bacterial infections play a critical role ...
Kaleido Scope6y
Pulmonary Fibrosis and Interstitial Lung Disease
The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). The University of ...